Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The total Bitcoin contract holdings across the network have reached a historic high, which may indicate that the price of the coin is about to break through

The total Bitcoin contract holdings across the network have reached a historic high, which may indicate that the price of the coin is about to break through

Bitget2024/07/29 10:23

BlockBeats reports that on July 29, according to CoinGlass data, the current total Bitcoin futures holdings reached $39.46 billion, surpassing the historical high of $39.03 billion set on March 29, 2024.

Analysts point out that this indicates an increased interest in Bitcoin among investors and may signal a breakthrough to new all-time highs for Bitcoin.

In addition, over 75% of short-term Bitcoin holders made a profit on July 24. This could translate into greater upward momentum for Bitcoin as short-term data is often used to measure retail demand for Bitcoin. (Cointelegraph)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56